Dr. Hani N. Sabbah, PhD
Henry Ford Hospital
Biography & Research Background
Hani N. Sabbah, PhD, is a Professor in the Department of Medicine, Division of Cardiovascular Medicine, at Henry Ford Hospital (Henry Ford Health) in Detroit, Michigan. He has conducted extensive translational research on elamipretide (SS-31) in heart failure models, demonstrating that chronic SC administration improves left ventricular function, reduces NT-proBNP, and restores mitochondrial respiration in a validated canine model of advanced heart failure. His work has also elucidated the anti-inflammatory mechanisms of SS-31 including NF-κB and NLRP3 inflammasome inhibition. Key publications: 'Chronic therapy with elamipretide improves left ventricular and mitochondrial function in dogs with advanced heart failure' (Circulation: Heart Failure, 2016) and 'Contemporary insights into elamipretide mechanism' (Biomedicine & Pharmacotherapy, 2025). In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Hani N. Sabbah, PhD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Hani N. Sabbah, PhD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.